Peptides in plain language

Updated October 2026 · 5 minute read

“Peptide” is a word about structure. It describes how a molecule is built. It says nothing about what a product does, who has reviewed it, or whether it belongs in your life.

This is general information for anyone considering a peptide program at any clinic, including ours. It is not medical or legal advice. You'll find no compound names here, and nothing on how much of anything to take or when. One section below explains why.

What a peptide is

A peptide is a short chain of amino acids, the same small units that proteins are built from. Length is the main difference between the two. A protein is built from long chains. A peptide is a short one.

That is the whole definition, and it covers a very large family. The name alone settles nothing: not what a particular peptide does, not whether anyone has reviewed it, not whether it is appropriate for you. The questions that matter begin where the vocabulary ends.

An approved drug and a compounded medication

Two very different things can arrive with a prescription label on them. A drug the FDA has approved has been through the agency's review before reaching patients: its safety, its effectiveness and its quality, for one specific product.

A compounded medication has not. Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness or quality before they reach patients. Under the federal rule that covers state-licensed compounding pharmacies, a compounded medication is prepared for an identified patient, based on a valid prescription. That rule is an exemption from FDA approval. It is not FDA approval.

Three more facts complete the picture.

• A compounded medication is not a generic. Asked whether the two are the same, the FDA answers no: a generic is approved by the agency, while “a compounded drug is not approved by FDA.” Be careful with anyone who calls one “the same as” an approved drug.
• The ingredients are restricted. Federal rules limit which ingredients a pharmacy may use in compounding, and the FDA's view of specific ingredients can change.
• The FDA says who compounding is for. Its stated position is that compounded drugs should be used only for patients whose medical needs cannot be met by a drug it has approved.

What “prescribed, and filled by a licensed pharmacy” tells you

You'll see some version of this sentence on many clinic websites, and you'll see it on this one: prescribed by a clinician, filled by a licensed compounding pharmacy. Each half says something real. Neither half says as much as it seems to.

• Prescribed means a clinician has made a decision about you, by name, and put their own name to it. The federal rule is built on exactly that: a valid prescription for an identified patient.
• Licensed means the pharmacy answers to a regulator. For a state-licensed pharmacy that is not registered with the FDA as an outsourcing facility, the state board of pharmacy generally has primary responsibility for day-to-day oversight.

What it does not tell you

It does not tell you the FDA has reviewed the medication, and it does not turn a compounded medication into an approved one. It also says nothing about whether the medication is right for you. That is what the clinician's review is for, and it is fair to ask how that review was done.

Why careful clinics don't publish a menu

Some clinic websites list peptides the way a restaurant lists dishes: names, amounts, schedules, a price beside each. Notice the order of events a menu implies. The product comes first, and the person is fitted to it afterward.

A prescription runs the other way. A clinician reviews the person, then decides whether anything should be prescribed at all. A clinic that keeps to that order has nothing to list in advance, because the answer depends on someone it hasn't met.

There is a regulatory reason as well. The FDA says prescription drug promotion by or on behalf of drug makers, compounders included, “must be truthful, non-misleading and accurate.” A menu is written for everyone, before a clinician has reviewed anyone. That is a hard way to be accurate about a prescription.

So a missing menu is not evasion. What a clinic can publish, and should, is how a program runs, who reviews it, how pricing is set and what follow-up looks like.

Questions to ask before starting any program

1. Who is the prescribing clinician, and will they review my history before anything is prescribed?
2. Is this a compounded medication? If so, has anyone told me plainly that it is not FDA-approved?
3. Is there a drug the FDA has approved for the same purpose? If there is, why is a compounded one being suggested for me?
4. Which pharmacy fills the prescription, and which state licenses it?
5. What is known about this medication, what isn't, and what are the risks? Will I have that in writing?
6. How long does the program run, who do I call with a question, and what happens at the end?
7. What happens to my program if the FDA's view of an ingredient changes?
8. What does it cost, in writing, before I commit to anything?
9. Will you share the plan with my own doctor?

A clinic that answers these easily has told you something. A clinic that answers with a menu has told you something too. For the wider picture, read what “not FDA-approved” actually means.

At Nuvira, peptide programs are structured, run 12–16 weeks and are reviewed by the treating clinician. A peptide is prescribed only when it is appropriate for you, and it is filled through a licensed compounding pharmacy. The plain version comes first: the program is elective, compounded medications are not FDA-approved, candidacy is decided at consultation, and no outcome is promised.